Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
COMPLETED
NCT02402595
PHASE1
Drug Interaction Study Between AVP-923 and Itraconazole and Between AVP-786 and Itraconazole in Healthy Adult Subejcts
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
View on ClinicalTrials.gov
Summary
The purpose of this study is to determine the effects of a potent CYP3A4 inhibitor, itraconazole, on the steady-state PK of AVP-923 and AVP-786.
Official title: A Phase 1, Single-center, Randomized, Double-blind, Double-dummy, Drug Interaction Study Between AVP-923 and Itraconazole, and Between AVP-786 and Itraconazole in Healthy Adult Subjects
Key Details
Gender
All
Age Range
18 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
24
Start Date
2015-03-01
Completion Date
2015-07-01
Last Updated
2026-04-28
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
AVP-923
DRUG
AVP-786
DRUG
Itraconazole
Locations (1)
Vince and Associates Clinical Research, Inc.
Overland Park, Kansas, United States